NEW YORK (GenomeWeb) – A Veterans Health Administration subcommittee has recommended about half of the pharmacogenetic tests it evaluated to be more widely implemented across its facilities.
The Clinical Pharmacogenetics Subcommittee of the VHA's Molecular Diagnostics Working Group was charged with developing recommendations for standardizing pharmacogenetic testing across the VHA, which provides healthcare services for more than nine million veterans.